Re: Zenith Shareholders

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

10-41

Rank: President [?]

Points: 1511 [?]

Votes: 12 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Shareholders

in response to

Re: Zenith Shareholders

KOO-KOO2

posted on Sep 01, 2021 01:20PM

0.89% Charalambos Katevatis 1,200,001 $300.0k 0% ???

They're still being confused with this other company!

0.89%

Charalambos Katevatis

1,200,001

$300.0k

https://www.pressreader.com/canada/stockwatch-daily/20210819/281505049295814

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply